Metraipolis › archive › dc_4d16bf9342bb

The impact of swithching faricimab in the treatment of neovascular age-related macular degeneration: a real-world analysis — Europe PMC PMID:40820046

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/40820046
DOI: 10.1007/s00417-[numero omesso]-5
License (as archived): solo-consultazione
Archived: 2026-11-10T13:47:04.426Z
SHA-256 of the archived text: d1d261f825d687dcff6ea17d1dfd599d5e6fbf8ab5ad5772da312c241288c326
Stable URL of this page: https://metraipolis.com/documento/dc_4d16bf9342bb

How to cite

The impact of swithching faricimab in the treatment of neovascular age-related macular degeneration: a real-world analysis — Europe PMC PMID:40820046 — Europe PMC (en), https://europepmc.org/article/MED/40820046 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4d16bf9342bb (Metraipolis archive dc_4d16bf9342bb, sha256 d1d261f825d687dcff6ea17d1dfd599d5e6fbf8ab5ad5772da312c241288c326)

BibTeX

@misc{dc4d16bf9342bb,
  title = {The impact of swithching faricimab in the treatment of neovascular age-related macular degeneration: a real-world analysis — Europe PMC PMID:40820046},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40820046},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4d16bf9342bb; sha256 d1d261f825d687dcff6ea17d1dfd599d5e6fbf8ab5ad5772da312c241288c326},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40820046. Agents can read the archived copy with the MCP tool read_document.